Clorox (CLX) PT Lowered to $160 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts CLX Hot Sheet
Price: $89.21 +1.38%
Rating Summary:
1 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 16
Rating Summary:
1 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 16
Join SI Premium – FREE
Morgan Stanley analyst Dara Mohsenian lowered the price target on Clorox (NYSE: CLX) to $160.00 (from $171.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Evercore ISI Upgrades Clorox (CLX) to In Line
- Hartford Financial Services (HIG) PT Lowered to $136 at Cantor Fitzgerald
- Marriott International (MAR) PT Raised to $402 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
